CIK 0001274737 · Non-accelerated filer<br>Smaller reporting company
EXAGEN INC.
Sign in to watch- Ticker
- XGN
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (760) 560-1501
- Business address
- 1261 LIBERTY WAY, VISTA, CA, 92081
- Former names
- EXAGEN DIAGNOSTICS INC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Executive or director change
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 76,511 shares (grant or award)
- 4 Grant or award President and CEO acquired 150,000 shares (grant or award)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale President and CEO sold 15,698 shares at $3.62 ($56,827)
- 4 Open-market sale President and CEO sold 11,430 shares at $3.61 ($41,262)
- 4 Open-market sale Chief Financial Officer sold 1,584 shares at $3.61 ($5,718)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 2 of 22 · 426 filings